Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Vivek B. Nooney"'
Publikováno v:
Thrombosis Research. 196:510-515
Introduction On-treatment platelet aggregability represents the major form of functional assessment for patients treated with P2Y12 receptor antagonists, with “high” on-treatment platelet aggregability (HTPA) predicting thrombotic risk. However H
Autor:
Doan T.M. Ngo, Jocasta Ball, Elaine M. Hylek, Saifei Liu, Melinda Carrington, Vincent Goh, Tamila Heresztyn, Vivek B. Nooney, Irene Stafford, John D. Horowitz, Nathan E.K. Procter, Nicola L. Hurst, Simon Stewart, Yuliy Y. Chirkov, Jeffrey S. Isenberg
Publikováno v:
International Journal of Cardiology. 179:160-165
Background: Clinical factors associated with thromboembolic risk in AF patients are well characterized and include new onset AF. Biochemically, AF is associated with inflammatory activation and impairment of nitric oxide (NO) signalling, which may al
Background and Hypotheses: The signal transduction pathway modulated by activation or blockade of platelet P2Y12 receptors is linked to PGE1-stimulated adenylate cyclase effects, but this link’s impact on P2Y12 receptor antagonist response is uncer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6149b602cdeb34f7008a4004ccd987
https://hdl.handle.net/11541.2/119860
https://hdl.handle.net/11541.2/119860
Background: Clopidogrel resistance is more common in patients with loss-of-function CYP2C19 genotypes. Since adenylate cyclase (AC) and soluble guanylate cyclase (sGC) pathways are variably impaired in patients with ischaemic heart disease, we tested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb1d669875bd3c00e2e9dcea0ce993b
https://hdl.handle.net/11541.2/119613
https://hdl.handle.net/11541.2/119613
Autor:
John D. Horowitz, R. De Caterina, Vivek B. Nooney, B. Raman, Yuliy Y. Chirkov, Nicola L. Hurst
The clinical efficacy of the P2Y12 receptor antagonist clopidogrel as an agent to prevent thrombotic events predominantly reflects its anti-aggregatory effects. Stent thrombosis in particular is more likely to occur in patients in whom clopidogrel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a94c6c25f65917b9052b8d74b8a922
https://hdl.handle.net/1959.8/153432
https://hdl.handle.net/1959.8/153432
Autor:
Anne P Ponniah, Sepehr Shakib, Louise Sheridan, Manya Angley, Lisa K Spurling, Des Colley, Vivek B. Nooney, Vaishali Padhye, Xin Jou Bong
Background: The period 7 to 10 days following hospital discharge is associated with a significant risk of medication misadventure, especially in high-risk patients. Aim: To investigate whether post-discharge hospital-initiated medication reviews (HIM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1097b21f3cedc385192c2a0b1f600972
https://hdl.handle.net/1959.8/123295
https://hdl.handle.net/1959.8/123295
Publikováno v:
Global Heart. 9:e208
Publikováno v:
Global Heart. 9:e108
Autor:
Nicola L. Hurst, Cher-Rin Chong, John D. Horowitz, Yuliy Y. Chirkov, Saifei Liu, Vivek B. Nooney, Giovanni Licari, Doan T.M. Ngo
Publikováno v:
Global Heart. 9:e107
Publikováno v:
European Heart Journal. 34:P4895-P4895